Marma Ayurveda Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 695.61%
- Profit Growth 3059.67%
- Ebitda 405.10%
- Net Worth 4.58%
- Total Assets 452.20%
About Marma Ayurveda
Marma Ayurveda Private Limited (MAPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 March 2018 (Six years and 11 months 1 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Nitesh Khonde and Lina Khonde serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MH2018PTC307114
- Company No.
307114
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Marma Ayurveda?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitesh Khonde  | Director | 26-Mar-2018 | Current |
| Lina Khonde | Director | 26-Mar-2018 | Current |
Financial Performance of Marma Ayurveda.
Marma Ayurveda Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 695.61% increase. The company also saw a substantial improvement in profitability, with a 3059.67% increase in profit. The company's net worth moved up by a moderate rise of 4.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Marma Ayurveda?
Unlock access to Marma Ayurveda's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Parijatak Ayurveda Private LimitedNitesh Khonde and Lina Khonde are mutual person
Projense Systems Private LimitedNitesh Khonde is a mutual person
- Narachi Ayurveda Private Limited
Lina Khonde is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Marma Ayurveda?
Unlock and access historical data on people associated with Marma Ayurveda, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Marma Ayurveda, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marma Ayurveda's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.